Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-09-28
1986-12-16
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
548561, 549 74, 514222, 549492, 560 38, 514247, 560250, 564164, 514255, 564220, 514256, 564305, 514331, 564440, 564442, 514357, 564443, 558426, 514365, 514378, 514381, 514383, 514400, 514406, 514427, 514438, 514471, 514651, 514654, 544 59, 544162, 544224, 544335, 544336, 546246, 546329, 548146, 548205, 548247, 548254, 548255, 548262, 548342, 548378, A61K 31135, C07C 87455
Patent
active
046297278
ABSTRACT:
Compounds of formula I ##STR1## in which n=0 or 1; in which, when n=0, R.sub.1 is H, an alkyl, a cycloalkyl, a cycloalkylmethyl, an alkenyl or, an alkynyl group a heterocyclic ring or an optionally substituted phenyl ring or when n=1, R.sub.1 is H or an alkyl group;
REFERENCES:
patent: 4443449 (1984-04-01), Jeffery
patent: 4522828 (1985-06-01), Jeffery et al.
V. P. Arya and S. J. Shenoy, Synthesis of New Heterocycles: Part XV-Synthesis of Novel Cyclic and Acyclic Sulphamides, Indian Journ. of Chem., vol. 14B, pp. 766-769 (1976); Chem. Abs. 87 23236s.
A. L. Mndzhoyan, et al., Substituted Acetic Acids XXXII, Aminoesters of 1-(Alpha-Naphthyl) Cycloalkane-1-Carboxylic Acids and 1-(Alpha-Naphthyl) Cycloalkane-1-Methyl Guanidines, Armyanskii Khimichesdii Zhurnal, vol. 29, No. 2, pp. 194-199 (1976); Chem. Abs. 85 32678y; translation included.
A. Kalir, et al., 1-Phenylcycloalkylamine Derivatives, Israel J. Chem. 5(5), pp. 223-229 (1967).
Kozlik Antonin
Wells Wilfred H.
Gerstl Robert
The Boots Company PLC
LandOfFree
Therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-245274